Skip to main content
Drug Metabolism and Disposition logoLink to Drug Metabolism and Disposition
. 2019 Oct;47(10):1231. doi: 10.1124/dmd.119.086348err

Correction to “Efavirenz Metabolism: Influence of Polymorphic CYP2B6 Variants and Stereochemistry”

PMCID: PMC6781592  PMID: 31562132

In the above article [Wang P-F, Neiner A and Kharasch ED (2019) Drug Metab and Dispos 47 (10): 1195-1205; DOI: https://doi.org/10.1124/dmd.119.086348], changes provided by the authors were accidentally omitted during the proofing stage. The following changes have been made to the HTML and PDF versions of the article:

In Table 1, column 1, all entries have been italicized.

In Table 2, column 1, the letter s has been replaced with the number 20; in the units of measure row, mM has been changed to μM.

In Table 3, column 1, third line from the bottom, the lower-case letter superscript b has been italicized. In footnote b, *,;x,. has been deleted. In the body of the table, the symbols *,;x,. have been deleted.

In Table 4, column 7, units of measure row, pmol…min/pmol has been changed to pmol/min per picomoles; mM has been changed to μM.

On page 1197, right column, first paragraph, the last sentence has been changed to: The POR activity was converted to POR content assuming that 3000 nmol of cytochrome c are reduced per minute per nanomoles POR at 23C (Guengerich et al., 2009).

On page 1203, right column, second paragraph from the bottom, the last sentence has been changed to: These findings further strengthen the rationale for patient genotyping (specifically for CUP2B6 516G>T, 785A>G, and 983T>C polymorphisms) and for CYP2B6 genetically-guided efavirenz dosing (Mukonzo et al., 2014; Vo and Varghese Gupta, 2016).

The compositor regrets these errors and any inconvenience they may have caused.


Articles from Drug Metabolism and Disposition are provided here courtesy of American Society for Pharmacology and Experimental Therapeutics

RESOURCES